News Desk
07 December 2025, 11:26 AM IST
Kerala has banned 10 allopathic medicines and seven Ayurvedic arishtas after they were found to be substandard, as authorities step up efforts against unsafe drugs.
Representational image
Thiruvananthapuram: The Kerala government has banned the sale of 10 allopathic medicines and seven Ayurvedic arishtams after they were found to be of substandard quality, as authorities intensify efforts against counterfeit and unsafe medicines.
Banned Ayurvedic medicines
Banned Medicine, each with a ten-year validity from its manufacturing date
Amritarishtam (Batch 0110)
Kanakasavam (0114)
Ashwagandharishtam (111)
Usirasavam (0117)
Kudajarishtam (0113)
Abhayarishtam (109) – all from Karunagappally Bala Herbals
Ashokaristam (0220) – from Karunagappally Shiva Ayurvedic Pharmaceuticals
The move follows previous crackdowns by the Drugs Control Department, which last month seized counterfeit inhaler medicines used by asthma patients. The seizure, involving medicines worth approximately Rs. 2 lakh, prompted action against Aswas Pharma, headquartered in Balaramapuram, Thiruvananthapuram, and Med World Pharma in Poonkunnam, Thrissur.
Banned allopathic medicines
The following allopathic drugs have also been banned due to quality concerns:
Rabeprazole Sodium Tablets IP 20 mg (Torab) manufactured by OAKSUN Lifesciences in Telangana, batch T25.018, expiring in December 2026
Montelukast and Levocetirizine Tablets (Lecet-M) produced by Spinka Pharma, batch LCM-5061 expiring in May 2027
Glimepiride Tablets IP 2 mg from Kerala State Drugs and Pharmaceuticals Ltd., batch GL 4142 expiring in October 2026
Ranitidine Oral Solution IP (Raani Drops) from Sresan Pharmaceuticals, batch SR-017 expiring in May 2026
Aceclofenac and Paracetamol Tablets (Richnac-P) from J M Laboratories in Himachal Pradesh, batch GT16375A expiring in October 2026
Cyproheptadine Hydrochloride Syrup (Hepsandin Syrup) from Sresan Pharmaceuticals, batch SR-086 expiring in November 2026
Clopidogrel and Aspirin Tablets (Clopidomed A-150) manufactured by Ikon Pharmachem in Dehradun, batch T250139, expiring in December 2026
Calcium and Vitamin D3 Tablets IP produced by Bangal Chemicals and Pharmaceuticals Ltd., batch T572514 expiring in July 2026
Clopidogrel and Aspirin Tablets IP from Theon Pharmaceuticals, batch GT250375 expiring in January 2027
Paracetamol and Tramadol Hydrochloride Tablets (Tracet) manufactured by Chimak Healthcare, batch LBHK25001, expiring in January 2028
Ciprofloxacin Hydrochloride Tablets IP 500 mg (Ciprodac-500) manufactured by Cadila Pharmaceuticals, batch JKBD24080 expiring in July 2027
Authorities have urged pharmacies, hospitals and patients to immediately stop selling or consuming these medicines. The crackdown is part of Kerala’s ongoing effort to ensure drug safety and combat counterfeit pharmaceuticals across the state.
Subscribe to our NewsletterGet Latest Mathrubhumi Updates in EnglishFollow
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.